| Followers | 27 |
| Posts | 19690 |
| Boards Moderated | 0 |
| Alias Born | 01/16/2026 |
Monday, April 27, 2026 5:00:29 PM
?????????????????????????
April 27, 2026 4:49 PM
Business Wire
????????1????14.00??????????
???????????????????(EV)?117?5,000????
?????????????????????????????????????????????????
(???????) --
Sun Pharmaceutical Industries Limited(Reuters:SUN.BO?Bloomberg:SUNP IN?NSE:SUNPHARMA?BSE:524715)(?????????/????????????????????)?Organon & Co.(NYSE:OGN)(???????)???????????????????1????14.00?????????????????????????????????????????????????????117?5,000???????
?????????????????????????????????????????????:https://www.businesswire.com/news/home/20260426702232/ja/
???????2021???????????????MSD???????????????????????????????????????????????????(HCP)?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????70????????140????????????????????????????????????????????????????????????????????????????6????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????/??????????????????????????????????????????????????????????????????10??????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????
-
?????124???????????????25?????1
-
????????/??????????????????
-
????27%??????????????????????????????
-
????????????????????????????????????3???
-
???7 ???????????
-
150??????????1?????????????????18????????????
-
EBITDA?????????????????????????????/EBITDA??2.3???????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????·?????????????????????????????????????????????(Reaching People and Touching Lives)?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????·?????????????????????????????????????????????????????????????????????????????·??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????·?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
????
-
??????????????????????100%??????????
-
?????????????????????????????????????????????
-
?????????????????????????????????????????????????????
-
??????????????????????????????????????????????????2027??????????????
2025?12?31????????????? ?????????62????????EBITDA19?????????????????????86??????????5?7,400???????????????????1?????????????4?4,000????????????????????2026?3?31??????????????????
?????????????
J.P.????·????????LLC(J.P. Morgan Securities LLC)?????????LLC(Jefferies LLC)????????????????????????
????&???LLP(White & Case LLP)????????????????????AZB & Partners???????????????????????????????
Citigroup Global Markets Asia Ltd.?JPMorgan Chase Bank, N.A.???????UFJ??(MUFG Bank, Ltd.)??????????????????????
????·?????·???·?????LLC(Morgan Stanley & Co. LLC)???????????????????????????·????·???·?????LLC(Goldman Sachs & Co. LLC)???????????????????????????·???·??????LLP(Sullivan & Cromwell LLP)???????????????????Cyril Amarchand Mangaldas???????????????????????????????
Sun Pharmaceutical Industries Limited(CIN - L24230GJ1993PLC019050)????
????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????20%????????????????????100?????????????????????????????????????????5???????????????????50?????????????????????????????????www.sunpharma.com ????????LinkedIn?X(?Twitter)????????????
Organon & Co.????
?????(NYSE:OGN)????????????????????????????????????????????????????????????????????????????????????????70????????????????????????????????????????????????????????????????????????????140?????????????????????????????
???????????????????????????????????????????????????????????????????????????????????www.organon.com ????????LinkedIn?Instagram?X?YouTube?TikTok????Facebook????????????
???????????????????
????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????will??expect??may???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????(i)??????????????(ii)??????????????????????????????????(iii)?????????????????????????????????????????????????????????????????????(iv)?????????????????????????????????(v)?????????????????????????????(?????????????????????????)?????????????????????????????????????????????(vi)??????????????????????????????????(?????????????????????????)?(vii)???????????????????????????·????????????????????????????????????????????????(viii)???????????????????????????????????????(ix)????????????????????????????????????????(x)??????????????????????????????????????????????????????(xi)?????????????????????????????????????????????????(xii)????????????????????????????(xiii)??????????????????(xiv)?????????Form 10-K??????????????SEC???????????????????SEC?????????????????????????????????????????????????????SEC???????www.sec.gov?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
????????????
??????????2026?4?26????????????????????????????????????????????????????????????????????????????????????????Schedule 14A?????????????????????????(??????????)????????SEC?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????(??????????)????SEC??????????????????????????????????????????????????????????????????SEC???????www.sec.gov ???????????????????????????? https://www.organon.com ????????????
?????????
SEC??????????????????????????????????????????????????????????????????????????????????????????????????????2026?4?24??SEC??????2026????????????????????????? https://www.sec.gov/ix?doc=/Archives/edgar/data/0001821825/000119312526177411/ogn-20260423.htm ????????2026?????????????????????????????????????????????????????????????????????SEC???????????????Form 3????????????????Form 4????????????????????????? https://www.sec.gov/edgar/browse/?CIK=1821825 ?????????????????????????(???????????????????????????????)?????????????????????????????????????????????????????????????????????????????????????
|
|
??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
businesswire.com????????????:https://www.businesswire.com/news/home/20260426702232/ja/
Sun Pharma:
Investors
Dr. Abhishek Sharma
+91 22 4324 2929
abhi.sharma@sunpharma.com
Media (Global)
Gaurav Chugh
+91 22 4324 5373
gaurav.chugh@sunpharma.com
Media (USA)
Rob Perry
robert.perry@sunpharma.com
Organon:
Investor Relations
Jen Halchak
Jennifer.halchak@organon.com
Media
Kate Vossen
Katherine.vossen@organon.com
Original: ?????????????????????????
Recent OGN News
- Organon to Present New Research on Access and Value at ISPOR 2026 • Business Wire • 05/15/2026 11:30:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/09/2026 12:31:38 AM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 05/07/2026 08:00:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2026 02:02:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/04/2026 12:46:54 PM
- La Commissione Europea (CE) approva POHERDY® (pertuzumab), messo a punto da Henlius e Organon, il primo biosimilare di PERJETA (pertuzumab) approvato in Europa • Business Wire • 04/30/2026 05:30:00 PM
- Europäische Kommission erteilt Marktzulassung für POHERDY® (Pertuzumab) von Henlius und Organon, das erste in Europa zugelassene Biosimilar zu PERJETA (Pertuzumab) • Business Wire • 04/30/2026 05:30:00 PM
- La Commission européenne (CE) approuve le POHERDY® (pertuzumab) de Henlius et Organon, premier médicament biosimilaire du PERJETA (pertuzumab) autorisé en Europe • Business Wire • 04/30/2026 03:17:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/30/2026 12:16:32 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/30/2026 11:50:16 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 11:48:45 AM
- Organon Reports Results for the First Quarter Ended March 31, 2026 • Business Wire • 04/30/2026 11:30:00 AM
- European Commission (EC) Approves Henlius and Organon's POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe • PR Newswire (US) • 04/29/2026 02:00:00 PM
- Organon Cancels First Quarter Earnings Call • Business Wire • 04/29/2026 11:30:00 AM
- European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe • Business Wire • 04/29/2026 09:30:00 AM
- Sun Pharma signe un accord définitif pour acquérir Organon • Business Wire • 04/28/2026 12:58:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/27/2026 09:18:27 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/27/2026 09:17:42 PM
- サンファーマ、オルガノン買収に関する正式契約を締結 • Business Wire • 04/27/2026 08:49:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/27/2026 07:58:02 PM
- Sun Pharma unterzeichnet endgültige Vereinbarung zur Übernahme von Organon • Business Wire • 04/27/2026 10:36:00 AM
- Organon Jumps 15% as Sun Pharma Agrees $11.8bn Buyout • IH Market News • 04/27/2026 10:11:06 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/27/2026 10:09:36 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/27/2026 10:06:01 AM
